We’re excited to share that GreenBone and Endocon have forged a strategic partnership to bring GreenBone’s groundbreaking bone substitute to Germany and Austria. With Endocon’s deep expertise and strong network in the orthopedic sector, they are the perfect partner to help us make a significant growth in these regions.

The first UK patient in this Post-Market Multicentre Study has been enrolled at Hull Royal Infirmary.

Big thanks to Prof. Sharma and the Orthopaedics Research Team at Hull University Teaching Hospitals NHS Trust for their dedication to enhancing orthopaedic care.

We are excited to announce the enrollment of the first patient for our OSsIRIS study at the University Medical Centre in Regensburg (Germany).

Thank you to the Team at the Department of Trauma Surgery,  led by Prof. Volker Alt, for this significant achievement.

We look forward to many more successful cases ahead.